Nhs Activation Of Sepharose 6

With 160 years of experience in supporting science, our people have the practical knowledge and creative expertise to think big, deliver fresh ideas, and develop innovative services to help you solve your most critical business challenges. We do this by: • Making lab and production operations more efficient and competitive • Offering a wide range of support and services • Lending expertise to improve quality and boost scientific productivity • Helping achieve innovation faster Over 1,200 VWRCATALYST associates are working worldwide today at industry-leading pharmaceutical, biotech, healthcare, education, industrial, and high-tech production institutions.

For more information on VWRCATALYST, call 1.888.793.2300 or email us. VWR enables the advancement of science by providing high-quality chemicals and services, customized to your product or manufacturing needs. We use operational excellence to deliver solutions that enable research, testing, production, and commercialization across the globe. Our Core Capabilities Include: • Custom Liquid Manufacturing • Custom Liquid Dosing and Packaging • Custom Powder Manufacturing • Powder Dosing and Packaging • Assembly and Finishing Contact VWR Custom Manufacturing Services at 1.800.932.5000. Terms & Conditions Thank you for visiting our site.

These terms and conditions of use are applicable to the United States, Canada and Puerto Rico websites (“collectively the Web Site”) operated by VWR (the “Company”). If you are accessing the Web Site from outside the United States, Canada, or Puerto Rico, please see the appropriate international website, available at www.vwr.com, for applicable terms and conditions. All users of the Web Site are subject to the following website terms and conditions of use (these “Terms of Use”). Please read these Terms of Use carefully before accessing or using any part of the Web Site.

By accessing or using the Web Site, you agree that you have read, understand and agree to be bound by these Terms of Use, as amended from time to time, as well as the Company Privacy Policy, which is hereby incorporated into these Terms of Use. If you do not wish to agree to these Terms of Use, do not access or use any part of the Web Site. The Company may revise and update these Terms of Use at any time without notice by posting the amended terms to the Web Site.

Your continued use of the Web Site means that you accept and agree to the revised Terms of Use. If you disagree with the Terms of Use (as amended from time to time) or are dissatisfied with the Web Site, your sole and exclusive remedy is to discontinue using the Web Site. Site Use The information contained on this Web Site is provided for informational purposes only. Although the information is believed to correct at the time of publishing, you should make your own determination as to its suitability for your use. Not all of the products or services described in this Web Site are available in all jurisdictions or to all potential customers, and nothing herein is intended as an offer or solicitation in any jurisdiction or to any potential customer where such offer or sale is not qualified.

Purchase of Products and Services These Terms and Conditions apply only to the use of the Web Site. Please note, the terms and conditions relating to service, product sales, promotions, and other related activities can be found at and those terms and conditions control any purchases of products or services from the Company. Interactive Features The Web Site may contain bulletin board services, chat areas, news groups, forums, communities, personal web pages, calendars, and/or other message or communication facilities designed to enable you to communicate with the public at large or with a group (collectively, 'Community Feature'). You agree to use the Community Feature only to post, send and receive messages and material that are proper and related to the particular Community Feature. You agree to use the Web Site only for lawful purposes.

Affinity coupling media, NHS-Activated. NHS-activated Sepharose™ 4 Fast Flow is composed of. High level of pre-activation gives a high degree of.

Specifically you agree not to do any of the following when using a Community Feature: 1. Defame, abuse, harass, stalk, threaten or otherwise violate the legal rights (such as rights of privacy and publicity) of others. Publish, post, upload, distribute or disseminate any inappropriate, profane, defamatory, infringing, obscene, indecent or unlawful topic, name, material or information. Upload files that contain software or other material protected by intellectual property laws (or by rights of privacy of publicity) unless you own or control the rights thereto or have received all necessary consents. Upload files that contain viruses, corrupted files, or any other similar software or programs that may damage the operation of another's computer. Intercept or attempt to intercept electronic mail not intended for you. Advertise or offer to sell or buy any goods or services for any business purpose, unless such Community Feature specifically allows such messages.

Conduct or forward surveys, contests, pyramid schemes or chain letters. Download any file posted by another user of a Community Feature that you know, or reasonably should know, cannot be legally distributed in such manner or that you have a contractual obligation to keep confidential (notwithstanding its availability on the Web Site). Falsify or delete any author attributions, legal or other proper notices or proprietary designations or labels of the origin or source of software or other material contained in a file that is uploaded. Misrepresent an affiliation with any person or organization. Engage in any other conduct that restricts or inhibits anyone’s use of the Web Site, or which, as determined by the Company, may harm the Company or users of the Web Site or expose them to liability. Violate any applicable laws or regulations or violate any code of conduct or other guidelines which may be applicable for any particular Community Feature.

Harvest or otherwise collect information about others, including e-mail addresses, without their consent. You understand and acknowledge that you are responsible for whatever content you submit, you, not the Company, have full responsibility for such content, including its legality, reliability and appropriateness. If you post in the name of or on behalf of your employer or another entity, you represent and warrant that you are authorized to do so.

By uploading or otherwise transmitting material to any area of the Web Site, you warrant that the material is your own or is in the public domain or otherwise free of proprietary or other restrictions and that you have the right to post it to the Web Site. Additionally, by uploading or otherwise transmitting material to any area of the Web Site you are granting the Company a irrevocable, royalty-free, worldwide right to publish, reproduce, use, adapt, edit and/or modify such material in any way, in any and all media now known or hereafter discovered, worldwide, including on the Internet and World Wide Web, for advertising, commercial, trade and promotional purposes, without additional limitation or compensation, unless prohibited by law, and without notice, review or approval. The Company reserves the right, but does not assume any responsibility, to (1) remove any material posted on the Web Site which the Company, in its sole discretion, deems inconsistent with the foregoing commitments, or otherwise inappropriate for any reason; and (2) terminate any user’s access to all or part of the Web Site.

However, the Company can neither review all material before it is posted on the Web Site nor ensure prompt removal of objectionable material after it has been posted. Accordingly, the Company assumes no liability for any action or inaction regarding transmissions, communications or content provided by third parties. The Company reserves the right to take any action it deems necessary to protect the personal safety of users of this Web Site and the public; however, the Company has no liability or responsibility to anyone for performance or nonperformance of the activities described in this paragraph. Your failure to comply with the provisions of (A) or (B) above may result in the termination of your access to the Web Site and may expose you to civil and/or criminal liability.

Special note about Community Feature Content Any content and/or opinions uploaded, expressed or submitted through any Community Feature or any other publicly available section of the Web Site (including password-protected areas), and all articles and responses to questions, other than the content explicitly authorized by the Company, are solely the opinions and responsibility of the person or entity submitting them and do not necessarily reflect the opinions of the Company. By way of example, any recommended or suggested use of products or services available from the Company that is posted through a Community Feature is not a sign of approval or recommendation by the Company. If you choose to follow any such recommendation you do so at your own risk. Links to Third Party Sites The Web Site may contain links to other websites on the internet. The Company is not responsible for the content, products, services or practices of any third party websites, including without limitation sites linked to or from the Web Site, sites framed within the Web Site or third party advertisements, and does not make representations regarding their quality, content or accuracy.

The presence of links from the Web Site to any third party website does not mean that we approve of, endorse or recommend that website. We disclaim all warranties, express or implied, as to the accuracy, legality, reliability or validity of any content on any third party website. Your use of third party websites is at your own risk and subject to the terms and conditions of use for such websites.

Proprietary Rights to Content You acknowledge and agree that the entire contents of the Web Site (including all information, data, software, graphics, text, images, logos, and/or other material) and the design, selection, collection, arrangement and assembly thereof, are proprietary to the Company and are protected by United States and international intellectual property laws. You are authorized only to use the content on the Web Site for personal use or legitimate business purposes.

The simplest, most common and versatile techniques for crosslinking or labeling peptides and proteins such as antibodies involve the use of chemical groups that react with primary amines (–NH2). Primary amines exist at the N-terminus of each polypeptide chain and in the side-chain of lysine (Lys, K) amino acid residues. These primary amines are positively charged at physiologic pH; therefore, they occur predominantly on the outside surfaces of native protein tertiary structures where they are readily accessible to conjugation reagents introduced into the aqueous medium.

Furthermore, among the available functional groups in typical biological or protein samples, primary amines are especially nucleophilic; this makes them easy to target for conjugation with several reactive groups. In fact, there are numerous synthetic chemical groups that will form chemical bonds with primary amines. These include isothiocyanates, isocyanates, acyl azides, NHS esters, sulfonyl chlorides, aldehydes, glyoxals, epoxides, oxiranes, carbonates, aryl halides, imidoesters, carbodiimides, anhydrides, and fluorophenyl esters. Most of these conjugate to amines by either acylation or alkylation.

Formaldehyde and glutaraldehyde are aggressive carbonyl (–CHO) reagents that condense amines via Mannich reactions and/or reductive amination. These compounds are used to fix and preserve tissues or cells for immunohistochemistry (IHC) applications. The isothiocyanate group is familiar to researchers who have used the traditional fluorescent labeling reagent called FITC (fluorescein isothiocyanate). However, NHS esters and imidoesters are the most popular amine-specific functional groups that are incorporated into reagents for protein crosslinking and labeling.

Selected amine-reactive chemical groups. The functional groups are frequently used in protein biology methods. This 45-page guide is of value to the novice as well as those who have previous experience with crosslinking reagents.

It begins with a basic discussion on crosslinking and the reagents that are used. The guide also contains a discussion on various applications where crosslinking has been applied, including the powerful label-transfer technique for identifying or confirming protein interactions. Crosslinking chemistry is addressed in an easy-to-follow format designed to convey the important information you need without getting lost in details. Each Pierce crosslinking reagent is shown along with its structure, molecular weight, spacer arm length and chemical reactivity. The handbook concludes with a list of excellent references on crosslinker use and a glossary of common crosslinking terms.

NHS ester reaction chemistry NHS esters are reactive groups formed by carbodiimide-activation of carboxylate molecules (see ). NHS ester-activated crosslinkers and labeling compounds react with primary amines in physiologic to slightly alkaline conditions (pH 7.2 to 9) to yield stable amide bonds.

The reaction releases N-hydroxysuccinimide (NHS). NHS ester reaction scheme for chemical conjugation to a primary amine. Plugsound Box Keygen Free.  R represents a labeling reagent or one end of a crosslinker having the NHS ester reactive group; P represents a protein or other molecule that contains the target functional group (i.e., primary amine).

Hydrolysis of the NHS ester competes with the primary amine reaction. The rate of hydrolysis increases with buffer pH and contributes to less-efficient crosslinking in less-concentrated protein solutions. The half-life of hydrolysis for NHS-ester compounds is 4 to 5 h at pH 7.0 and 0°C. This half-life decreases to 10 mins at pH 8.6 and 4°C. The extent of NHS-ester hydrolysis in aqueous solutions free of primary amines can be measured at 260 to 280 nm, because the NHS byproduct absorbs in that range.

NHS-ester crosslinking reactions are most commonly performed in phosphate, carbonate-bicarbonate, HEPES or borate buffers at pH 7.2 to 8.5 for 0.5 to 4 h at room temperature or 4°C. Primary amine buffers such as Tris (TBS) are not compatible, because they compete for reaction; however, in some procedures, it is useful to add Tris or glycine buffer at the end of a conjugation procedure to quench (stop) the reaction. Low concentrations of sodium azide (≤ 3 mM or 0.02%) or thimerosal (≤ 0.02 mM or 0.01%) generally do not significantly interfere with NHS-ester reactions, but higher concentrations do interfere. Impure glycerol and high concentrations (20-50%) of glycerol also decrease reaction efficiency. Sulfo-NHS esters are identical to NHS esters except that they contain a sulfonate (–SO3) group on the N-hydroxysuccinimide ring. This charged group has no effect on the reaction chemistry, but it does tend to increase the water-solubilty of crosslinkers containing them. In addition, the charged group prevents Sulfo-NHS crosslinkers from permeating cell membranes, enabling them to be used for cell surface crosslinking methods.

Sulfo-NHS ester reaction scheme for chemical conjugation to a primary amine. R represents a labeling reagent or one end of a crosslinker having the sulfo-NHS ester reactive group; P represents a protein or other molecule that contains the target functional group (i.e., primary amine, –NH2). The solubility of NHS-ester reagents varies with buffer composition and the physical properties of the remainder of the molecular structure (e.g., spacer arm). Many non-sulfonated forms of NHS-ester reagents are water-insoluble and must be dissolved in a water-miscible organic solvent, such as DMSO and DMF, before they can be added to an aqueous reaction mixture. Thus, crosslinking reactions with the water-insoluble NHS-esters typically require an organic solvent-carryover of 0.5 to 10% final volume in the aqueous reaction.

NHS vs. Sulfo-NHS crosslinkers. Structures of and (Sulfo-DSS) amine-to-amine crosslinkers. DSS is not directly water-soluble but once dissolved can permeate across cell membranes to crosslink inside cells.

BS3 is water-soluble (at usual working concentrations) but, being charged, cannot permeate cell membranes; this confines BS3 crosslinking to the surface of intact cells. Bioconjugate Techniques, 3 rd Edition (2013) by Greg T. Hermanson is a major update to a book that is widely recognized as the definitive reference guide to the field of bioconjugation. Bioconjugate Techniques is a complete textbook and protocols-manual for life scientists wishing to learn and master the biomolecular crosslinking, labeling, and immobilization techniques that form the basis of many laboratory applications. The book is also an exhaustive and robust reference for researchers looking to develop novel conjugation strategies for entirely new applications. It also contains an extensive introduction to the field of bioconjugation that covers all of the major applications of the technology used in diverse scientific disciplines as well as containing tips for designing the optimal bioconjugate for any purpose.

Homobifunctional crosslinkers that have NHS ester groups at both ends, such as DSS and BS 3 shown above, are primarily used in applications where the goal is to covalently (permanently) bond together binding partners in protein complexes. Although conjugation can occur between primary amines of any two (same or different) protein molecules, only those proteins that are nonrandomly closely associated in a binding relationship will become crosslinked with sufficient frequency in the entire population of molecules to detect in analysis. Unless the goal is random polymerization, these amine-to-amine crosslinkers are seldom used to crosslink purified proteins that have no binding relationship. This technique can be applied to discover or validate a protein interaction or to analyze the conditions in which a known protein interaction occurs.

Experiments can be done in vitro (with complex lysates or purified putative interacting proteins) or in vivo (intracellular or cell surface). With proper controls, the relative abundance of conjugates of different size and identity (determined by electrophoresis and staining or Western blotting) will be indicative of specific interactions at the time of crosslinking. By comparing results using crosslinkers with different spacer arm lengths or different cleavability or solubility features, different characteristics of an interaction can be elucidated. Heterobifunctional NHS-ester crosslinkers, in particular those with opposite ends that contain a photo-activatable group, are particularly useful for protein interaction analysis. These linkers can be reacted first to a purified 'bait' protein (via NHS-ester reaction to primary amines) and then added to cells or a lysate to allow the bait protein to interact with the 'prey' protein.

When desired, the second end of the linker can be activated (with UV-light) so that it attaches to whatever chemical group it first encounters. In a protein interaction complex, the reaction will result in crosslinks between bait and prey protein interactors. The following western blot analysis provides an example of crosslinking regents that are used in vivo.

Comparison of several in vivo crosslinking methods. HeLa cells treated with 1% Formaldehyde (HCHO) or 1 mM homobifunctional NHS-ester crosslinker (Thermo Scientific and ) in PBS for 10 mins before quenching. A fourth set of HeLa cells were treated and crosslinked for 10 mins with 4 mM, 2 mM (Photo-AA) according to the procedure (see subsequent section). Formaldehyde-treated and NHS-ester-treated cells were quenched with 100 mM glycine pH 3 and 500 mM Tris pH 8.0, respectively for an additional 15 mins. One million cells from each condition were then lysed and 10 µg of each sample was heated at 65°C for 10 mins in reducing sample buffer containing 50 mM DTT and analyzed by SDS-PAGE and western blotting with Stat3 specific antibodies (Cell Signaling). GAPDH (Santa Cruz) and beta-actin (US Biologicals) were blotted as loading controls. Heterobifunctional crosslinkers that have an NHS ester group at one end and a different reactive group at the other end (such as a sulfhydryl-reactive maleimide) can be used to create specific protein conjugates. One example is the conjugation of a purified antibody with horseradish peroxidase enzyme to yield an antibody-HRP conjugate for use in ELISA.

Another example is conjugation of peptide antigens to KLH or other carrier protein to prepare an effective immunogen. Is the crosslinker most often use for this method. Crosslinkers are like SMCC but have different spacer arm lengths based on the number of polyethylene glycol (PEG) units they contain. Because different functional groups are involved, the reaction can be done in a controlled, step-wise manner. In both of these examples, the amines of one protein can be activated in isolation using the NHS-ester reactive group; when the second protein (bearing sulfhydryl groups) is added, it conjugates to each molecule of the first protein that had been activated. Commonly needed proteins, such as HRP or KLH, are commercially available in pre-activated form (i.e., in which the NHS ester reaction with SMCC is already complete).

In this representative experiment, a cysteine coupling assay was used to assess the levels of maleimide activated carrier proteins. High levels of maleimide activation of Thermo Scientific Imject Carrier Proteins.

Surface primary amines (i.e., lysine side chains) of Imject Carrier Proteins were maleimide activated by reaction with excess Thermo Scientific Pierce crosslinker. Activation levels (moles of maleimide per gram of carrier protein) were determined with a cysteine coupling assay. KLH and Blue Carrier Proteins are very large (approx. 8000 kDa), enabling activation with 600 to 900 maleimide groups per protein molecule. BSA and ovalbumin are smaller (67 kDa and 45 kDa, respectively), allowing for activation with 5 to 20 maleimide groups per protein molecule. The most popular and effective biotinylation and fluorescent labeling reagents for antibodies and proteins are NHS-ester compounds.

There are at least two reasons for this popularity, availability and widespread use in labeling applications: • Biotin and many fluorescent compounds naturally contain or are easily synthesized with a carboxyl group, which can be easily derivatized using carbodiimide chemistry (usually DCC) to produce the NHS-ester compound. • The most common targets for labeling are large proteins like antibodies (MW of IgG is 150,000), which have 10 to 15 readily available lysine amines with which NHS-ester compounds can react to attach the desired affinity or detection tag. To generate the he fluorescent western blot data that follows, a fluorophore conjugated secondary antibody was used to detect the target protein, ERK1 in cancer cell lysate.

Infrared western blot detection of ERK1 using DyLight 755-conjugated secondary antibody. Serial dilutions of A562 cell lysates were analyzed by western blotting for levels of ERK1 using a mouse anti-ERK1 primary antibody and a goat anti-mouse secondary antibody conjugated to DyLight 755 (using the). Left lane: Infrared molecular weight marker. Immobilize antibodies and other proteins Beaded agarose resin, magnetic particles and several other types of solid supports are available in forms that are activated with NHS-ester groups. These activated supports will stably and efficiently conjugate with proteins or other amine-containing ligands to immobilize them for use in affinity purification procedures. As described above, NHS esters hydrolyze easily; therefore, NHS-agarose and similar activated resins are always supplied dry or slurried in organic solvent (usually acetone). An important alternative to NHS esters for protein immobilization to agarose beads is aldehyde-activated resin for conjugation by reductive amination. For more information on this related amine-immobilization method (AminoLink Products), see the page on.

In addition, homobifunctional NHS crosslinkers like DSS, described above, are frequently used to retain an antibody on the beads during immunoprecipitation (IP) procedures. This 'Crosslink IP' method (also called IgG Orientation) involves first binding the purified IP-antibody to the Protein A/G agarose resin, then adding DSS to covalently crosslink the affinity-bound antibody and Protein A/G molecules through respective primary amines. This representative protein gel provides an example of results generated using the crosslink IP method. Specific protein purification using IgG coupled to NHS-activated agarose. Human IgG (25 mg) was immobilized on 1mL of. The affinity resin was used to purify secreted recombinant Protein G from E. A final yield of 25 mg of protein was obtained. Lane 1: bacterial pellet, Lane 2: MW marker, Lane 3: culture supernatant, Lane 4: flow-through, Lanes 5-12: elutions, Lane 13: boiled resin following elutions.

Imidoester crosslinkers react with primary amines to form amidine bonds. Imidoester crosslinkers react rapidly with amines at alkaline pH but have short half-lives. As the pH becomes more alkaline, the half life and reactivity with amines increases; therefore, crosslinking is more efficient when performed at pH 10 than at pH 8. Reaction conditions below pH 10 may result in side reactions, although amidine formation is favored between pH 8-10. Studies using monofunctional alkyl imidates reveal that at pH. Homobifunctional imidoester crosslinkers have been used to study protein structure and molecular associations in membranes and to immobilize proteins onto solid-phase supports.

The resulting amidine is protonated and therefore has a positive charge at physiologic pH; to some degree, this preserves the native charge properties of the original amines it replaces, and this may be useful in certain experiments. Imidoester crosslinkers also have been examined as a substitute for glutaraldehyde for tissue fixation. Despite their charge properties, imidoesters can penetrate cell membranes and crosslink proteins within the membrane to study membrane composition, structure and protein:protein and protein:lipid interactions. These crosslinkers have also been used to determine or confirm the number and location of subunits within multi-subunit proteins. In these experiments, large molar excesses of crosslinker (100- to 1000-fold) and low concentrations of protein (less than 1mg/mL) are used to favor intramolecular over intermolecular crosslinking.

Although imidoesters are still used in certain procedures, the amidine bonds formed are reversible at high pH. Therefore, the more stable and efficient NHS-ester crosslinkers have steadily replaced them in most applications.

Shelf life Please be aware this product may be shipped 90 days before the expiration date. For more information on the batch specific expiration date, please contact technical service. Please be aware this product may be shipped 90 days before the expiration date. For more information on the batch specific expiration date, please contact technical service. Packaging pack of 25 mL mfr. GE Healthcare, 17-0906-01 matrix 4% cross-linked agarose particle size 45-165 μm average diameter 90 μm cleaning in place 3 - 13 (Ligand dependent) ligand dependent 3 - 13 working range 3 - 12 (3 (ligand dependent)-12 (ligand dependent)) suitability suitable for bioprocess medium storage temp. Analysis Note To view the Certificate of Analysis for this product, please visit.

Features and Benefits • NHS pre-activated medium for coupling of small amino-containing proteins and peptides in process-scale applications • High level of pre-activation gives a high degree of substitution of the selected ligand • NHS coupling method results in chemically stable ligand attachment • BioProcess medium supported for industrial applications General description NHS-activated Sepharose ® 4 Fast Flow is a pre-activated agarose matrix that increases the choice of coupling chemistries available. Suitable for coupling amino-containing smaller proteins and peptides. NHS-activated Sepharose ® 4 Fast Flow is composed of cross-linked 4% agarose beads, NHS activated for coupling amino-containing proteins and peptides in process-scale applications.

NHS (N-hydroxysuccinimide) coupling forms a chemically stable amide bond with ligands containing primary amino groups. This resin provides a spacer arm to the coupled ligand and is therefore particularly suitable for immobilising smaller protein and peptide ligands. NHS-activated Sepharose ® 4 Fast Flow is available in a range of different bulk pack sizes and convenient pre-packed formats for easy scale-up and process development. As member of the BioProcess media range, NHS-activated Sepharose ® 4 Fast Flow meets industrial demands with security of supply and comprehensive technical and regulatory support. Legal Information Sepharose is a registered trademark of GE Healthcare.